Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,386 | 1,523 | 1,514 | 1,491 | 1,618 |
| Gross Profit | 2,386 | 1,523 | 1,514 | 1,491 | 1,618 |
| Operating Expenses | 18,799 | 16,740 | 14,655 | 14,526 | 15,081 |
| Operating Income | -16,413 | -15,217 | -13,141 | -13,035 | -13,463 |
| Interest Expense | 797 | 1,074 | 1,099 | 1,041 | 994 |
| Other Income | 168 | -2,464 | 153 | 215 | -10,197 |
| Pre-tax Income | -17,042 | -18,755 | -14,087 | -13,861 | -24,654 |
| Net Income Continuous | -17,042 | -18,755 | -14,087 | -13,861 | -24,654 |
| Net Income | $-17,042 | $-18,755 | $-14,087 | $-13,861 | $-24,654 |
| EPS Basic Total Ops | -0.23 | -0.27 | -0.25 | -0.25 | -0.46 |
| EPS Basic Continuous Ops | -0.20 | -0.24 | -0.20 | -0.20 | -0.41 |
| EPS Diluted Total Ops | -0.23 | -0.27 | -0.25 | -0.25 | -0.46 |
| EPS Diluted Continuous Ops | -0.20 | -0.24 | -0.20 | -0.20 | -0.41 |
| EBITDA(a) | $-15,926 | $-14,727 | $-12,640 | $-12,535 | $-12,956 |